Pseudopheochromocytoma induced by anxiolytic withdrawal
详细信息    查看全文
  • 作者:Alida Páll ; Gergely Becs ; Annamária Erdei…
  • 关键词:Anxiolytic drugs ; Pseudopheochromocytoma ; Hypertension ; Psychopharmacology
  • 刊名:European Journal of Medical Research
  • 出版年:2014
  • 出版时间:December 2014
  • 年:2014
  • 卷:19
  • 期:1
  • 全文大小:1,520 KB
  • 参考文献:1. Kuchel, O (1985) Pseudopheochromocytoma. Hypertension 7: pp. 151-158 CrossRef
    2. Sharabi, Y, Goldstein, DS, Bentho, O, Saleem, A, Pechnik, S, Geraci, MF, Holmes, C, Pacak, K, Eisenhofer, G (2007) Sympathoadrenal function in patients with paroxysmal hypertension: pseudopheochromocytoma. J Hypertens 25: pp. 2286-2295 CrossRef
    3. Mann, SJ (2008) Severe paroxysmal hypertension (pseudopheochromocytoma). Curr Hypertens Rep 10: pp. 12-18 CrossRef
    4. Hunt, J, Lin, J (2008) Paroxysmal hypertension in a 48-year-old woman. Kidney Int 74: pp. 532-535 CrossRef
    5. Seck, SM, Ka, EF, Niang, A, Diouf, B (2009) Pseudopheochromocytoma: an uncommon cause of malignant hypertension. Indian J Nephrol 19: pp. 122-124 CrossRef
    6. Hamada, M, Shigematsu, Y, Mukai, M, Kazatani, Y, Kokubu, T, Hiwada, K (1995) Blood pressure response to the Valsalva maneuver in pheochromocytoma and pseudopheochromocytoma. Hypertension 25: pp. 266-271 CrossRef
    7. Hickman, PE, Leong, M, Chang, J, Wilson, SR, McWhinney, B (2009) Plasma free metanephrines are superior to urine and plasma catecholamines and urine catecholamine metabolites for the investigation of phaeochromocytoma. Pathology (Phila) 41: pp. 173-177
    8. Mackenzie, IS, Brown, MJ (2007) Pseudopheochromocytoma. J Hypertens 25: pp. 2204-2206 CrossRef
    9. Lenders, JWM, Pacak, K, Walther, MM, Linehan, WM, Mannelli, M, Friberg, P, Keiser, HR, Goldstein, DS, Eisenhofer, G (2002) Biochemical diagnosis of pheochromocytoma: which test is best?. JAMA J Am Med Assoc 287: pp. 1427-1434 CrossRef
    10. Bravo, EL (1994) Evolving concepts in the pathophysiology, diagnosis, and treatment of pheochromocytoma. Endocr Rev 15: pp. 356-368 CrossRef
    11. Katon W, Roy-Byrne PP: Panic disorder in the medically ill. / J Clin Psychiatry 1989, 50.
    12. White, WB, Baker, LH (1986) Episodic hypertension secondary to panic disorder. Arch Intern Med 146: pp. 1129-1130 CrossRef
    13. Krentz AJ, Mikhail S, Cantrell P, Hill GM: Drug points: pseudophaeochromocytoma syndrome associated with clozapine. / BMJ 2001, 322.
    14. Zornitzki, T, Knobler, H, Schattner, A (2007) Reboxetine treatment and pseudopheochromocytoma. QJM Mon J Assoc Physicians 100: pp. 61-62 CrossRef
    15. Balon, R, Ortiz, A, Pohl, R, Yeragani, VK (1988) Heart rate and blood pressure during placebo-associated panic attacks. Psychosom Med 50: pp. 434-438 CrossRef
    16. Cameron, OG, Lee, MA, Curtis, GC, McCann, DS (1987) Endocrine and physiological changes during ‘spontaneous-panic attacks. Psychoneuroendocrinology 12: pp. 321-331 CrossRef
    17. Fogarty, J, Engel, C, Russo, J (1994) Hypertension and pheochromocytoma testing: the association with anxiety disorders. Arch Fam Med 3: pp. 55-60
    18. Manger WM, Gifford RWJ, Hoffman BB: Pheochromocytoma: a clinical and experimental overview. / Curr Probl Cancer 1985, 9.
    19. Pacak, K, Linehan, WM, Eisenhofer, G, Walther, MM, Goldstein, DS (2001) Recent advances in genetics, diagnosis, localization, and treatment of pheochromocytoma. Ann Intern Med 134: pp. 315-329
文摘
Background Symptomatic paroxysmal hypertension without significantly elevated catecholamine concentrations and with no evidence of an underlying adrenal tumor is known as pseudopheochromocytoma. Methods We describe the case of a female patient with paroxysmal hypertensive crises accompanied by headache, vertigo, tachycardia, nausea and altered mental status. Previously, she was treated for a longer period with alprazolam due to panic disorder. Causes of secondary hypertension were excluded. Neurological triggers (intracranial tumor, cerebral vascular lesions, hemorrhage, and epilepsy) could not be detected. Results Setting of the diagnosis of pseudopheochromocytoma treatment was initiated with alpha- and beta-blockers resulting in reduced frequency of symptoms. Alprazolam was restarted at a daily dose of 1?mg. The patient’s clinical condition improved rapidly and the dosage of alpha- and beta-blockers could be decreased. Conclusions We conclude that the withdrawal of an anxiolytic therapeutic regimen may generate sympathetic overdrive resulting in life-threatening paroxysmal malignant hypertension and secondary encephalopathy. We emphasize that pseudopheochromocytoma can be diagnosed only after exclusion of the secondary causes of hypertension. We highlight the importance of a psychopharmacological approach to this clinical entity.

© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号

地址:北京市海淀区学院路29号 邮编:100083

电话:办公室:(+86 10)66554848;文献借阅、咨询服务、科技查新:66554700